FDA Controlled Substances Legal Framework Health Policy European Medicines Agency NPPA Drug Enforcement Health Authorities
European regulators conclude that finasteride and dutasteride pose a potential risk of suicidal ideation but affirm their benefits outweigh the risks for approved uses.